The global clinical next-generation sequencing (NGS) data analysis market opportunity enjoys a valuation of USD 2.3 Billion in 2023, and it is further projected to expand at a CAGR of 17.4% over the ...
Visitors to the National Gallery of Singapore (NGS) can soon look forward to a guide to take them through the art pieces in the museums - but not just any guide, an artificial guide (AI) by the name ...
Global liquid biopsy company ANGLE, has granted genomics and molecular diagnostics company, NuProbe USA, Inc. use of its proprietary pan-cancer next generation sequencing (NGS) panel. Under the ...